Cargando…

Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis

The prevalence of non-alcoholic fatty liver disease (NAFLD), ranging from simple steatosis to inflammatory steatohepatitis (NASH) and cirrhosis, continues to rise, making it one of the major chronic liver diseases and indications for liver transplantation worldwide. The pathological processes underl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoebinger, Constanze, Rajcic, Dragana, Hendrikx, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784685/ https://www.ncbi.nlm.nih.gov/pubmed/35083304 http://dx.doi.org/10.3389/fcvm.2021.824481

Ejemplares similares

Chronic-binge ethanol feeding aggravates systemic dyslipidemia in Ldlr (-/-) mice, thereby accelerating hepatic fibrosis
por: Hoebinger, Constanze, et al.
Publicado: (2023)

Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and atherosclerosis
por: Mo, Shuangyang, et al.
Publicado: (2023)

CML/RAGE Signal Bridges a Common Pathogenesis Between Atherosclerosis and Non-alcoholic Fatty Liver
por: Pang, Qiwen, et al.
Publicado: (2020)

Relationship between lifestyle and metabolic factors and carotid atherosclerosis: A survey of 47,063 fatty and non-fatty liver patients in China
por: Zhang, Chun, et al.
Publicado: (2022)

Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease
por: Hendrikx, Tim, et al.
Publicado: (2020)

Optoacoustic biomarkers of lipids, hemorrhage and inflammation in carotid atherosclerosis
por: Karlas, Angelos, et al.
Publicado: (2023)

Impact of advanced liver fibrosis on atrial fibrillation recurrence after ablation in non-alcoholic fatty liver disease patients
por: Wang, Zhe, et al.
Publicado: (2022)

Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer: An Integrative View
por: Lee-Rueckert, Miriam, et al.
Publicado: (2022)

Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality
por: Ng, Cheng Han, et al.
Publicado: (2022)

Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction
por: Yang, Zifeng, et al.
Publicado: (2023)

Association of mean arterial pressure with non-alcoholic fatty liver disease: results from the NAGALA study
por: Li, Xinghui, et al.
Publicado: (2023)

Role of Lipid Accumulation and Inflammation in Atherosclerosis: Focus on Molecular and Cellular Mechanisms
por: Malekmohammad, Khojasteh, et al.
Publicado: (2021)

Salvia miltiorrhiza Bge. (Danshen) in the Treating Non-alcoholic Fatty Liver Disease Based on the Regulator of Metabolic Targets
por: Liu, Jie, et al.
Publicado: (2022)

Association Between Non-alcoholic Fatty Liver Disease and Risk of Stroke: A Systematic Review and Meta-Analysis
por: Wang, Meng, et al.
Publicado: (2022)

Association of non-alcoholic fatty liver disease with left ventricular changes in treatment-naive patients with uncomplicated hypertension
por: Catena, Cristiana, et al.
Publicado: (2022)

Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non‐alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2022)

Role of PCSK9 in Homocysteine-Accelerated Lipid Accumulation in Macrophages and Atherosclerosis in ApoE(−/−) Mice
por: Jin, Ping, et al.
Publicado: (2021)

Paradoxical reduction of plasma lipids and atherosclerosis in mice with adenine-induced chronic kidney disease and hypercholesterolemia
por: Padalkar, Mugdha V., et al.
Publicado: (2023)

Non-alcoholic Fatty Liver Disease Is Associated With Cardiovascular Outcomes in Subjects With Prediabetes and Diabetes: A Prospective Community-Based Cohort Study
por: Song, Qi-Rui, et al.
Publicado: (2022)

Non-alcoholic Fatty Liver Disease and the Risk of Incident Atrial Fibrillation in Young Adults: A Nationwide Population-Based Cohort Study
por: Choi, JungMin, et al.
Publicado: (2022)

THU586 Lipid Species In Non-alcoholic Fatty Liver Disease (NAFLD) In Type 1 Diabetes
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

Effects of ω-3 Polyunsaturated Fatty Acids on Coronary Atherosclerosis and Inflammation: A Systematic Review and Meta-Analysis
por: Gao, Zheng, et al.
Publicado: (2022)

The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study
por: Dai, Wen, et al.
Publicado: (2021)

Gender-based differences in the relationship between fatty liver disease and atherosclerosis
por: Kim, Hyun-Jin, et al.
Publicado: (2016)

Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes
por: Hu, Xiaomin, et al.
Publicado: (2022)

Common Polymorphisms in the RGMa Promoter Are Associated With Cerebrovascular Atherosclerosis Burden in Chinese Han Patients With Acute Ischemic Cerebrovascular Accident
por: Hu, Qingzhe, et al.
Publicado: (2021)

Case report: Coronary atherosclerosis in a patient with long-standing very low LDL-C without lipid-lowering therapy
por: Mottola, Giorgio, et al.
Publicado: (2023)

Paraoxonase 1 and atherosclerosis
por: Durrington, Paul N., et al.
Publicado: (2023)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
por: Wang, BingYu, et al.
Publicado: (2021)

Gender-Based Association of Coronary Artery Calcification and Framingham Risk Score With Non-alcoholic Fatty Liver Disease and Abdominal Obesity in Taiwanese Adults, a Cross-Sectional Study
por: Tsou, Meng-Ting, et al.
Publicado: (2022)

Endothelial Transcytosis of Lipoproteins in Atherosclerosis
por: Zhang, Xinbo, et al.
Publicado: (2018)

Pulse Wave Velocity in Atherosclerosis
por: Kim, Hack-Lyoung, et al.
Publicado: (2019)

Editorial: Atherosclerosis and functional imaging
por: Huang, Jei-Yie, et al.
Publicado: (2022)

The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
por: Finney, Alexandra C., et al.
Publicado: (2023)

Vasculoprotective Role of Olive Oil Compounds via Modulation of Oxidative Stress in Atherosclerosis
por: Summerhill, Volha, et al.
Publicado: (2018)

Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis
por: Jiang, Hui, et al.
Publicado: (2022)

Targeting Trimethylamine N-Oxide: A New Therapeutic Strategy for Alleviating Atherosclerosis
por: Jing, Lele, et al.
Publicado: (2022)

CARF (CDKN2AIP) Regulates Hepatic Lipid Metabolism and Protects Against Development of Non-Alcoholic Fatty Liver Diseases
por: Hasan, Kamrul M, et al.
Publicado: (2021)

The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients
por: Ganjooei, Narges Ashraf, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eu6vm35jajke1ga8atp0uek4d8